Brief: Scandinavian ChemoTech Resolves On Rights Issue Of About SEK 13.8 Mln
May 24 (Reuters) - Scandinavian ChemoTech AB
CMOTECb.ST :
* BOD RESOLVES ON A RIGHTS ISSUE OF SHARES OF ABOUT SEK
13.84
MILLION
* SUBSCRIPTION PRICE IS SEK 1.80 PER CLASS B SHARE
* SUBSCRIPTION PERIOD IN THE RIGHTS ISSUE RUNS FROM 4 JUNE
2024 UP
TO AND INCLUDING 18 JUNE 2024
Source text for Eikon: ID:nWkr4HtsQx
Further company coverage: CMOTECb.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Scandinavian ChemoTech AB
See all newsBrief: Chemotech Enters Strategic Partnership With University Of Copenhagen's Veterinary Hospitals
Brief: Scandinavian Chemotech Secures SEK 6 Mln Growth Loan
Brief: ChemoTech: Outcome Of Directed Issue
Sweden's ChemoTech Q1 net sales rise, loss narrows on US operation improvement
Brief: ChemoTech Q1 Sales SEK 2.798 Million